Febustat 20mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby lowering serum urate levels and preventing the formation of urate crystals that cause gout attacks. This medication is typically prescribed for patients who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. Febustat 20mg is effective in both the treatment and prevention of gout flares and is often part of a long-term management plan to maintain target uric acid levels below 6 mg/dL. It is important to take this tablet exactly as prescribed by a healthcare professional, usually once daily, with or without food. Patients should be monitored regularly for liver function and cardiovascular status, as Febuxostat may have associated risks in individuals with pre-existing heart conditions. Common side effects include nausea, joint pain, and rash, though serious adverse effects are rare. Febustat 20mg should be used cautiously in patients with renal or hepatic impairment and is not recommended during pregnancy or breastfeeding. Always consult a doctor before starting or stopping this medication.